Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ARID1A |
| Variant | S552* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | ARID1A S552* results in a premature truncation of the Arid1a protein at amino acid 552 of 2285 (UniProt.org). S552* has not been characterized, however, due to the effects of other truncation mutations downstream of S552 (PMID: 29736026), is predicted to lead to a loss of Arid1a protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ARID1A mutant ARID1A inact mut ARID1A S552* |
| Transcript | NM_006015.6 |
| gDNA | chr1:g.26731456C>A |
| cDNA | c.1655C>A |
| Protein | p.S552* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_139135.4 | chr1:g.26731456C>A | c.1655C>A | p.S552* | RefSeq | GRCh38/hg38 |
| NM_006015.6 | chr1:g.26731456C>A | c.1655C>A | p.S552* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ARID1A S552* | urinary bladder cancer | sensitive | Tulmimetostat | Preclinical - Cell culture | Actionable | In a preclinical study, Tulmimetostat inhibited viability in 5/6 bladder cancer cell lines harboring ARID1A loss of function mutations including ARID1A S552* in culture (PMID: 38833522). | 38833522 |